generic drug manufacturers

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

295 documents for generic drug manufacturers

- Supreme Court Denies Leave To Appeal In Proposed $3.9 Billion Class Action Against Generic Drug Manufacturers
The Supreme Court of Canada has released today its judgment in the case of Option Consommateurs v. Novopharm et al dismissing, with costs, Option Con...
- Mondaq Business Briefing
- Canada Law Articles in English
- Teva Canada Limited v. Canada (Health), 2012 FCA 106 (2012)
... Health placed Sanofi-Aventis Canada Inc.’s drug, Eloxatin, on a register of “innovative drugs”...It had been genericized in Canada and around the world. Yet, in 2007, the ...Generic drug manufacturers often follow this route. It allows these manufactu...
- Federal Court of Appeal
- Manitoba Sticking with Generic Drug Arrangement
... now signs with generic drug manufacturers guarantees Manitoba gets the lowest price possible...
- Winnipeg Free Press
- April 12, 2010

- Teva Canada Limited c. Canada (Health), 2011 FC 507 (2011)
... issues important to the innovator and generic drug manufacturer industries in Canada: what is th... invites innovator and generic manufacturers to engage in the dialogue as outlined in the Minis...
- Cour Fédérale
- Canadian Generic Pharmaceutical Association v. Canada (Health), 2009 FC 725 (2009)
... Data Protection Regulation ) of the Food and Drug Regulations, C.R.C., c. 870 (the FDA Regulations)....), an association of generic drug manufacturers and their suppliers. The Respondent is Canada, as ...
- Federal Court
- Teva Canada Limited v. Canada (Health), 2011 FC 507 (2011)
... issues important to the innovator and generic drug manufacturer industries in Canada: what is th... invites innovator and generic manufacturers to engage in the dialogue as outlined in the Minis...
- Federal Court
- Pfizer Canada Inc. c. Novopharm Limited, 2010 FC 409 (2010)
... (“PMNOC Regulations”) in relation to the drug pregabalin. [2] In response to the NOA, on Novembe... NOA confidential, but the eyes of other generic drug manufacturers who are already in a the proces...
- Cour Fédérale
- New Revisions To The Health Canada Patented Medicines (Notice Of Compliance) Regulations Guidance Document
... with respect to whether administrative drug submissions submitted by a generic manufacturer pu... agreement between two generic drug manufacturers. Under Health Canada's drug review process, when a...
- Mondaq Business Briefing
- Canada Law Articles in English
- Apotex Inc. v. Canada (Health), 2010 FCA 334 (2010)
...Docket: A-360-09. BETWEEN:. CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION. Appellant and. ATTORNE... that subsection 30(3) of the Food and Drugs Act , R.S. 1985, c. F-25 (the Act) and section... a period of market exclusivity for manufacturers of innovative drug[s] by imposing an eight-yea...
- Federal Court of Appeal
- Pharmacapsules @ Gowlings - July 16, 2010
... Ontario Regulations made under the Ontario Drug Benefit Act and The Drug Interchangeability and Di... into effect reducing the price of most generic drugs by at least 50 per cent and eliminating so-c... allowances" paid by generic drug manufacturers to pharmacies. Instead, the province has increased...
- Mondaq Business Briefing
- Canada Law Articles in English